and/or

571 Blog posts found

In the Clinic

Pumped Up: Implanted Chemotherapy Device Improves Survival when Colorectal Cancer Spreads to the Liver

A retrospective study from MSK has found that colorectal cancer patients with liver metastases live an average of two years longer when they receive an additional treatment called hepatic arterial infusion (HAI).

Image of liver with tumors

In the Clinic

MSK Expert Explains New Prostate Cancer Screening Guideline

MSK surgeon James Eastham explains the pros and cons of PSA testing and weighs in on a new US Preventive Services Task Force guideline.

James Eastham, Chief of the Urology Service at Memorial Sloan Kettering

Finding

Blood Will Tell: Scientists Find Clues to Immunotherapy Responders and Non-Responders

Why do some patients respond to immunotherapy while others do not? Blood may hold the answer.

photo of blood vials

Finding

#AACR17: Childhood Cancer Survivors Found to Have Inherited Mutations Increasing Risk of the Disease

MSK geneticist and pediatric oncologist Michael Walsh discusses new findings on inherited mutations in pediatric cancer survivors.

MSK geneticist and pediatric oncologist Michael Walsh

Finding

#AACR17: Novel Drug Advancing to Phase II Basket Trial of Solid Tumors

Learn more about entrectinib, a targeted therapy being evaluated in patients with solid tumors.

Physician standing in front of a whiteboard

Finding

#AACR17: Researchers Shed Light on Biological Activity of a New, First-in-Class Immunotherapy

A team at MSK uncovered how TRX518, a new immunotherapy drug in early development, works in the body.

Grey T lymphocytes

Finding

#AACR17: New Data Show Some Patients with Melanoma Live Longer When Receiving Immunotherapy Combination

For some patients with metastatic melanoma, a combination of two immunotherapies works better than either drug alone.

Finding

#AACR17: Study Explores Best Time to Give CAR T Cell Therapy

Leukemia patients may do better on CAR T cell therapy when they are treated early, before their disease relapses.

immune cells

Finding

#AACR17: Basket Trial for Experimental Drug Shows Promising Early Results

Neratinib, which targets mutations that drive cancer growth, is showing promise for treating several types of cancer.

David Hyman and Robin Gillespie

In the Clinic

Does an Aspirin a Day Reduce the Risk of Colorectal Cancer?

MSK gastroenterologist Robin Mendelsohn weighs in on the possible benefits and drawbacks of using aspirin to reduce the risk of colon and rectal cancer.